Market Niche Focus Stockton Labs specializes in developing overlooked generic pharmaceuticals, creating opportunities to serve niche markets or less competitive segments that larger manufacturers may neglect.

Innovative Product Launches With recent launch of FDA-approved products like Sdamlo, Stockton demonstrates agility and innovation, positioning itself to capitalize on emerging market demands for specialized oral solutions.

Manufacturing Capabilities Owning a CMO liquid manufacturing facility allows Stockton to offer customized, high-quality production services to other pharmaceutical companies, opening partnership and outsourcing revenue streams.

Growth Potential With revenue estimated between $10 million and $25 million and a specialized product pipeline, Stockton has opportunities for targeted expansion within the generic drug market, especially in small to mid-sized segments.

Technology Backbone Utilizing advanced tech tools like cloud management and modern web frameworks, Stockton is well-positioned to enhance operational efficiencies, digital marketing, and supply chain transparency to attract new partners and clients.